Always purchase FSSAI-certified, NABL lab-tested supplements from reputable brands to ensure consistent quality
Back to Journals Drug Design, Development and Therapy Volume 20 GLP-1 Receptor Agonists in Neurological Disorders: From Mechanisms to Clinical Translation Received 1 April 2026 Accepted for publication 2 June 2026 Published 12 June 2026 Volume 2026:20 613616 DOI Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 4 Editor who approved publication: Professor Anastasios Lymperopoulos Pengpeng Li, Yangyang Gao, Wei Liu Department of Neurosurgery, Xian Aerospace Hospital of Northwest University, Xian, Shanxi, 710000, Peoples Republic of China Correspondence: Pengpeng Li, Email [email protected] Wei Liu, Email [email protected] Abstract: Glucagon-like peptide-1 receptor agonists, or GLP-1RAs, have been used for years to treat type 2 diabetes and obesity
Does Ulta Beauty carry any exclusive The Ordinary products
Their primary benefit is weight management, which may indirectly improve metabolic health and reduce cardiovascular risk factors associated with perimenopause
The findings revealed that this fraction significantly enhanced diuretic and natriuretic effects while maintaining potassium levels
Metabolic engineering of the l-serine biosynthetic pathway improves glutathione production in Saccharomyces cerevisiae